ALK-Abello's Incubator/Accelerator Round

ALK-Abello raised a round of funding on , . Investors include Sirti.

ALK is a research-driven global pharmaceutical company focusing on allergy treatment, prevention and diagnosis. Our mission is to improve the quality of life of persons with allergy by developing phar…

Articles about ALK-Abello's Incubator/Accelerator Round: